Table of Content
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 OVERVIEW OF THE INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET
1.4 LIMITATIONS
1.5 MARKETS COVERED
2 MARKET SEGMENTATION
2.1 MARKETS COVERED
2.2 GEOGRAPHICAL SCOPE
2.3 YEARS CONSIDERED FOR THE STUDY
2.4 CURRENCY AND PRICING
2.5 DBMR TRIPOD DATA VALIDATION MODEL
2.6 MULTIVARIATE MODELLING
2.7 PRODUCT TYPE LIFELINE CURVE
2.8 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS
2.9 DBMR MARKET POSITION GRID
2.1 MARKET END USER COVERAGE GRID
2.11 VENDOR SHARE ANALYSIS
2.12 SECONDARY SOURCES
2.13 ASSUMPTIONS
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 PESTEL ANALYSIS
4.2 PORTER’S FIVE FORCES
4.3 PRICING STRATEGY
4.4 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, CONJOINT ANALYSIS
4.4.1 FEATURE- CUSTOMIZATION
4.4.2 FEATURE- ADDITIONAL SERVICES
5 REGULATORY COMPLIANCE
5.1 REGULATORY AUTHORITIES:
5.2 REGULATORY SCENARIO IN INDIA -
6 MARKET OVERVIEW
6.1 DRIVERS
6.1.1 USE OF SYNTHESIZED OLIGONUCLEOTIDES IN VARIOUS APPLICATIONS
6.1.2 INCREASING GOVERNMENT INVESTMENTS AND R&D EXPENDITURE
6.2 RESTRAINTS
6.2.1 RISING COMPETITION AMONG MARKET PLAYERS
6.2.2 LACK OF TRAINED PROFESSIONALS
6.3 OPPORTUNITY
6.3.1 RISING TECHNOLOGICAL ADVANCEMENTS
6.4 CHALLENGE
6.4.1 LIMITATION OF OLIGONUCLEOTIDES SYNTHESIS
7 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE
7.1 OVERVIEW
7.2 CUSTOM OLIGOS
7.3 PREDESIGNED OLIGOS
8 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY PRODUCT TYPE
8.1 OVERVIEW
8.2 EQUIPMENT'S
8.2.1 OLIGOSYNTHESIZER
8.2.1.1 SMALL SCALE SYNTHESIS
8.2.1.2 MEDIUM SCALE SYNTHESIS
8.2.1.3 LARGE SCALE SYNTHESIS
8.2.2 COMPUTER-CONTROLLED INSTRUMENTS
8.2.2.1 COLUMN FORMAT
8.2.2.2 MULTI-WELL PLATE FORMAT
8.3 REAGENTS, CONSUMABLES & ACCESSORIES
8.3.1 CAPPING REAGENTS
8.3.2 ACTIVATOR SOLUTION
8.3.2.1 ACTIVATOR SOLUTION (DCI)
8.3.2.2 ACTIVATOR SOLUTION (ETT)
8.3.2.3 ACTIVATOR SOLUTION (BTT)
8.3.2.4 OTHERS
8.3.3 OXIDIZER
8.3.4 DEBLOCK SOLUTION
8.3.4.1 DEBLOCK DCM SOLUTION
8.3.4.2 DEBLOCK DCE SOLUTION
8.3.5 COUPLING
8.3.5.1 ANHYDROUS ACETONITRILE
8.3.5.2 ACTIVATORS
8.3.6 DEPROTECTED REAGENTS
8.3.7 OTHERS
9 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY SYNTHESIS METHOD
9.1 OVERVIEW
9.2 SOLID PHASE OLIGO SYNTHESIS METHOD
9.2.1 COLUMN-BASED OLIGONUCLEOTIDE SYNTHESIS
9.2.2 MICROARRAY-BASED OLIGONUCLEOTIDE SYNTHESIS
9.3 LIQUID/ENZYMATIC PHASE OLIGO SYNTHESIS METHOD
9.3.1 TEMPLATE INDEPENDENT POLYMERASE-BASED METHOD
9.3.2 TEMPLATE-DEPENDENT POLYMERASE MEDIATED OLIGO SYNTHESIS
10 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY APPLICATION
10.1 OVERVIEW
10.2 DIAGNOSTICS
10.2.1 INFECTIOUS DISEASES
10.2.2 CANCER
10.2.3 NEUROLOGICAL DISEASE
10.2.4 CARDIOVASCULAR DISEASE
10.2.5 OTHERS
10.3 THERAPEUTICS
10.3.1 RNAI OLIGONUCLEOTIDE-BASED THERAPIES
10.3.2 DNA/ANTISENSE OLIGONUCLEOTIDE-BASED THERAPIES
10.3.3 IMMUNOTHERAPY (CPG OLIGONUCLEOTIDE-BASED THERAPIES)
10.3.4 NUCLEIC ACID APTAMERS
10.4 RESEARCH
10.4.1 APTAMER DESIGN
10.4.2 ALLELE-SPECIFIC TESTING
10.4.3 TRIPLEX-FORMING OLIGONUCLEOTIDES
10.4.4 OTHER RESEARCH APPLICATIONS
10.5 AGRICULTURE
10.6 FOOD
10.7 OTHERS
11 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY END USER
11.1 OVERVIEW
11.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
11.3 DIAGNOSTIC CENTERS
11.4 CONTRACT RESEARCH ORGANIZATION
11.5 RESEARCH & ACADEMIC INSTITUTES
11.6 FORENSIC LABS
12 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL
12.1 OVERVIEW
12.2 DIRECT TENDER
12.3 RETAIL SALES
12.4 OTHERS
13 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, COMPANY LANDSCAPE
13.1 COMPANY SHARE ANALYSIS: INDIA
14 COMPANY PROFILE
14.1 THERMO FISHER SCIENTIFIC
14.1.1 COMPANY SNAPSHOT
14.1.2 REVENUE ANALYSIS
14.1.3 PRODUCT PORTFOLIO
14.1.4 RECENT DEVELOPMENTS
14.2 AGILENT TECHNOLOGIES INC
14.2.1 COMPANY SNAPSHOT
14.2.2 REVENUE ANALYSIS
14.2.3 PRODUCT PORTFOLIO
14.2.4 RECENT DEVELOPMENTS
14.3 MERCK KGAA
14.3.1 COMPANY SNAPSHOT
14.3.2 REVENUE ANALYSIS
14.3.3 PRODUCT PORTFOLIO
14.3.4 RECENT DEVELOPMENT
14.4 DANAHER
14.4.1 COMPANY SNAPSHOT
14.4.2 REVENUE ANALYSIS
14.4.3 PRODUCT PORTFOLIO
14.4.4 RECENT DEVELOPMENT
14.5 LGC LIMITED
14.5.1 COMPANY SNAPSHOT
14.5.2 PRODUCT PORTFOLIO
14.5.3 RECENT DEVELOPMENT
14.6 AJINOMOTO BIO-PHARMA
14.6.1 COMPANY SNAPSHOT
14.6.2 PRODUCT PORTFOLIO
14.6.3 RECENT DEVELOPMENT
14.7 EUROFINS GENOMICS
14.7.1 COMPANY SNAPSHOT
14.7.2 PRODUCT PORTFOLIO
14.7.3 RECENT DEVELOPMENT
14.8 GENERAL ELECTRIC
14.8.1 COMPANY SNAPSHOT
14.8.2 REVENUE ANALYSIS
14.8.3 PRODUCT PORTFOLIO
14.8.4 RECENT DEVELOPMENT
14.9 METTLER TOLEDO INDIA PRIVATE LTD
14.9.1 COMPANY SNAPSHOT
14.9.2 PRODUCT PORTFOLIO
14.9.3 RECENT DEVELOPMENT
14.1 TRILINK BIOTECHNOLOGIES, LLC
14.10.1 COMPANY SNAPSHOT
14.10.2 PRODUCT PORTFOLIO
14.10.3 RECENT DEVELOPMENT
15 QUESTIONNAIRE
16 RELATED REPORTS
List of Table
TABLE 1 THE AVERAGE COST OF OLIGONUCLEOTIDES SYNTHESIS IN INDIA:
TABLE 2 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 3 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY PRODUCT TYPE, 2021-2030 (USD MILLION)
TABLE 4 INDIA EQUIPMENT'S IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 5 INDIA OLIGOSYNTHESIZER IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 6 INDIA COMPUTER-CONTROLLED INSTRUMENTS IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 7 INDIA REAGENTS, CONSUMABLES & ACCESSORIES IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 8 INDIA ACTIVATOR SOLUTION IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 9 INDIA DEBLOCK SOLUTION IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 10 INDIA COUPLING IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 11 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY SYNTHESIS METHOD, 2021-2030 (USD MILLION)
TABLE 12 INDIA SOLID PHASE OLIGO SYNTHESIS METHOD IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 13 INDIA LIQUID/ENZYMATIC PHASE OLIGO SYNTHESIS METHOD IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 14 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY APPLICATION, 2021-2030 (USD MILLION)
TABLE 15 INDIA DIAGNOSTICS IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 16 INDIA THERAPEUTICS IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 17 INDIA RESEARCH IN OLIGONUCLEOTIDES SYNTHESIS MARKET, BY TYPE, 2021-2030 (USD MILLION)
TABLE 18 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY END USER, 2021-2030 (USD MILLION)
TABLE 19 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET, BY DISTRIBUTION CHANNEL, 2021-2030 (USD MILLION)
List of Figure
FIGURE 1 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: SEGMENTATION
FIGURE 2 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: DATA TRIANGULATION
FIGURE 3 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: DROC ANALYSIS
FIGURE 4 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: GLOBAL VS REGIONAL MARKET ANALYSIS
FIGURE 5 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: COMPANY RESEARCH ANALYSIS
FIGURE 6 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: INTERVIEW DEMOGRAPHICS
FIGURE 7 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: DBMR MARKET POSITION GRID
FIGURE 8 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: MARKET END USER COVERAGE GRID
FIGURE 9 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: VENDOR SHARE ANALYSIS
FIGURE 10 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: SEGMENTATION
FIGURE 11 INCREASING APPLICATION OF OLIGONUCLEOTIDES SYNTHESIS IS EXPECTED TO DRIVE THE GROWTH OF THE INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET IN THE FORECAST PERIOD
FIGURE 12 THE CUSTOM OLIGOS SEGMENT IS EXPECTED TO ACCOUNT FOR THE LARGEST SHARE OF THE INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET IN 2023 AND 2030
FIGURE 13 DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES OF THE INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET
FIGURE 14 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: BY TYPE, 2022
FIGURE 15 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: BY PRODUCT TYPE, 2022
FIGURE 16 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: BY SYNTHESIS METHOD, 2022
FIGURE 17 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: BY APPLICATION, 2022
FIGURE 18 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: BY END USER, 2022
FIGURE 19 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: BY DISTRIBUTION CHANNEL, 2022
FIGURE 20 INDIA OLIGONUCLEOTIDES SYNTHESIS MARKET: COMPANY SHARE 2022 (%)
